Tandem Diabetes Care (TNDM) FCF Margin Growth (3y) (2016 - 2026)
Tandem Diabetes Care (TNDM) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 60.00 |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -764.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -764.00 |
| Mar 31, 2026 | 1,797.00 |
| Dec 31, 2025 | -146.00 |
| Sep 30, 2025 | -1,342.00 |
| Jun 30, 2025 | -627.00 |
| Mar 31, 2025 | -1,658.00 |
| Dec 31, 2024 | 89.00 |
| Sep 30, 2024 | -1,018.00 |
| Jun 30, 2024 | -2,255.00 |
| Mar 31, 2024 | -2,618.00 |
| Dec 31, 2023 | -1,117.00 |
| Sep 30, 2023 | 1,439.00 |
| Jun 30, 2023 | -2,648.00 |
| Mar 31, 2023 | 1,195.00 |
| Dec 31, 2022 | -918.00 |
| Sep 30, 2022 | 61.00 |
| Jun 30, 2022 | -41.00 |
| Mar 31, 2022 | 1,396.00 |
| Dec 31, 2021 | -1,234.00 |
| Sep 30, 2021 | 2,867.00 |